Deep vein thrombosis inhibitor may play a therapeutic role in post-stroke patients.

Xixi XiangDi YuanPeiyan KongTing ChenHan YaoShijia LinXi ZhangHongbao Cao

Published in: BMC medical genetics (2020)

Our results suggested that DVT inhibitor SP1 could be a novel therapeutic target gene for post-stroke treatment. Further study of the potential relations between SP1 and stroke was guaranteed.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
atrial fibrillation
copy number
genome wide
dna methylation
combination therapy
replacement therapy